Plenty of near term catalysts yet to come to fruit
Post# of 30026
Posted On: 08/05/2014 9:10:40 AM
Plenty of near term catalysts yet to come to fruition. While time lines can change in a fluid environment, these events are coming..
GC, when will we learn who our target partner is that BD is handing LymPro off to?
We expect to complete the agreement by the end of the summer.
Does AMBS expect to have a big pharma partner for one or more MANF indications before uplisting?
We expect to complete the agreement by the end of the summer.
How are Grant applications going, can you say how many apps are filed, when can expect to hear about news on this Front.
We have submitted 6 applications to date, and are working on more for the August deadline.
What is the timeline for the first Orphan Drug application with MANF?
2H-2014
When do you expect to issue revenue guidance for Lympro?
In our 2nd quarter conference call.
Will there be any forthcoming publications from the Bascom Palmer Institute re: Retinitis Pigmentosa and MANF?
Yes. We were told later this year
GC, when will we learn who our target partner is that BD is handing LymPro off to?
We expect to complete the agreement by the end of the summer.
Does AMBS expect to have a big pharma partner for one or more MANF indications before uplisting?
We expect to complete the agreement by the end of the summer.
How are Grant applications going, can you say how many apps are filed, when can expect to hear about news on this Front.
We have submitted 6 applications to date, and are working on more for the August deadline.
What is the timeline for the first Orphan Drug application with MANF?
2H-2014
When do you expect to issue revenue guidance for Lympro?
In our 2nd quarter conference call.
Will there be any forthcoming publications from the Bascom Palmer Institute re: Retinitis Pigmentosa and MANF?
Yes. We were told later this year
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼